Back
89bio Vs. Akero Therapeutics Industry Stock Comparison
Buy
53
ETNB
89bio
Last Price:
8.71
Seasonality Move:
16.3%
Sell
42
AKRO
Akero Therapeutics
Last Price:
19.65
Seasonality Move:
6.97%
Buy
53
89bio (ETNB)
is a Buy
Is 89bio a Buy, Sell or Hold?
- The current 89bio [ETNB] share price is $9.12. The Score for ETNB is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- ETNB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $20.80. The Score for AKRO is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- AKRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ETNB Stock Price Chart
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $20.80
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight selling pressure.
ETNB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.36 | Sell |
| Relative Strength Index (14 RSI): | 44.48 | Sell |
| Chaikin Money Flow: | -217579 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.57 - 10.09) | Sell |
| Bollinger Bands (100): | (9.3 - 11.9) | Sell |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.64 | Sell |
| Relative Strength Index (14 RSI): | 45.35 | Sell |
| Chaikin Money Flow: | -91962 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.89 - 22.35) | Sell |
| Bollinger Bands (100): | (20.29 - 26.05) | Sell |
ETNB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.06 | Buy |
| 20-day SMA: | 9.01 | Buy |
| 50-day SMA: | 10.66 | Sell |
| 200-day SMA: | 11.49 | Sell |
| 8-day EMA: | 9.09 | Buy |
| 20-day EMA: | 9.28 | Sell |
| 50-day EMA: | 9.95 | Sell |
| 200-day EMA: | 11.23 | Sell |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.66 | Buy |
| 20-day SMA: | 20.71 | Buy |
| 50-day SMA: | 23.96 | Sell |
| 200-day SMA: | 27.75 | Sell |
| 8-day EMA: | 20.83 | Sell |
| 20-day EMA: | 21.13 | Sell |
| 50-day EMA: | 22.33 | Sell |
| 200-day EMA: | 26.85 | Sell |
89bio Earnings Growth & ETNB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.08 per share, a decrease this year of $0.01 per share, and a decrease next year of $0.32 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.19 per share, a decrease this year of $1.01 per share, and a decrease next year of $0.65 per share.
89bio Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||